The effect of brotowali (Tinospora crispa L.) stem ethanolic extract on the inhibition of Candida albicans biofilm formation
Downloads
Downloads
Moyes DL, Naglik JR. Mucosal immunity and Candida albicans infection. Clin Dev Immunol. 2011; 2011: 346307.
Kadosh D. Regulatory mechanisms controlling morphology and pathogenesis in Candida albicans. Curr Opin Microbiol. 2019; 52: 27–34.
Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral candidiasis: A disease of opportunity. J fungi (Basel, Switzerland). 2020; 6(1): 15.
Singh A, Verma R, Murari A, Agrawal A. Oral candidiasis: An overview. J Oral Maxillofac Pathol. 2014; 18(Suppl 1): S81-5.
Kabir MA, Hussain MA, Ahmad Z. Candida albicans: A model organism for studying fungal pathogens. ISRN Microbiol. 2012; 2012: 538694.
Kim J, Sudbery P. Candida albicans, a major human fungal pathogen. J Microbiol. 2011; 49(2): 171–7.
Nobile CJ, Johnson AD. Candida albicans Biofilms and Human Disease. Annu Rev Microbiol. 2015; 69: 71–92.
Lestari PE. Peran faktor virulensi pada patogenesis infeksi Candida albicans. Stomatognaic - J Kedokt Gigi. 2010; 7(2): 113–7.
Pereira R, Dos Santos Fontenelle RO, de Brito EHS, de Morais SM. Biofilm of Candida albicans: formation, regulation and resistance. J Appl Microbiol. 2021; 131(1): 11–22.
Ponde NO, Lortal L, Ramage G, Naglik JR, Richardson JP. Candida albicans biofilms and polymicrobial interactions. Crit Rev Microbiol. 2021; 47(1): 91–111.
Perlin DS. Echinocandin resistance in Candida. Clin Infect Dis. 2015; 61(Suppl 6): S612-7.
Arendrup MC, Patterson TF. Multidrug-resistant Candida: Epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017; 216(suppl_3): S445–51.
Aminul H, M IAS, Mohammad S. Antimicrobial, cytotoxicity and antioxidant activity of Tinospora crispa. J Pharm Biomed Sci. 2011; 13(12): 1–4.
Ahmad W, Jantan I, Bukhari SNA. Tinospora crispa (L.) Hook. f. & Thomson: A review of its ethnobotanical, phytochemical, and pharmacological aspects. Front Pharmacol. 2016; 7: 59.
Zuza-Alves DL, Silva-Rocha WP, Chaves GM. An update on Candida tropicalis based on basic and clinical approaches. Front Microbiol. 2017; 8: 1927.
Hutomo S, Putri DU, Welviyanda BC, Susilowati H. Inhibition effect of garlic (Allium sativum) extract on Streptococcus sanguinis biofilm formation involving bacterial motility mechanism. Malaysian J Med Heal Sci. 2021; 17(2): 169–74.
Raja AF, Ali F, Khan IA, Shawl AS, Arora DS. Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res Notes. 2011; 4: 406.
Siswomihardjo W, Sunarintyas S, Tontowi AE. The effect of zirconia in hydroxyapatite on staphylococcus epidermidis growth. Int J Biomater. 2012; 2012: 432372.
Setiawati S, Nuryastuti T, Ngatidjan N, Mustofa M, Jumina J, Fitriastuti D. In vitro antifungal activity of (1)-N-2-Methoxybenzyl-1,10-phenanthrolinium bromide against Candida albicans and its effects on membrane integrity. Mycobiology. 2017; 45(1): 25–30.
Warsinah, Harwoko, Nuryanti. Screening of volatile compounds of brotowali (Tinospora crispa) and antifungal activity against Candida albicans. Int J Pharmacogn Phytochem Res. 2015; 7(1): 132–6.
Inci M, Atalay MA, Özer B, Evirgen Ö, Duran N, Köksaldi Motor V, Koç AN, Önlen Y, Kilinç Ç, Durmaz S. Investigations of ALS1 and HWP1 genes in clinical isolates of Candida albicans. Turkish J Med Sci. 2013; 43(1): 125–30.
Tits J, Cammue BPA, Thevissen K. Combination therapy to treat fungal biofilm-based infections. Int J Mol Sci. 2020; 21(22): 8873.
Huang X, Zheng M, Yi Y, Patel A, Song Z, Li Y. Inhibition of berberine hydrochloride on Candida albicans biofilm formation. Biotechnol Lett. 2020; 42(11): 2263–9.
Burhannuddin B, Karta IW, Tresnanda B, Putra IGND, Darmada IPA, Pradnyadhita, IIDA, Gunawan IWBA, Ariawan IMB. Daya hambat virgin coconut oil terhadap pertumbuhan jamur Candida albicans yang diisolasi dari sampel swab vagina. JST (Jurnal Sains dan Teknol). 2017; 6(2): 209–19.
Gan R. Bioactivities of berberine : An update. Int J Mod Biol Med. 2012; 1(1): 48–81.
da Silva AR, de Andrade Neto JB, da Silva CR, Campos R de S, Costa Silva RA, Freitas DD, do Nascimento FBSA, de Andrade LND, Sampaio LS, Grangeiro TB, Magalhí£es HIF, Cavalcanti BC, de Moraes MO, Nobre Júnior HV. Berberine antifungal activity in fluconazole-resistant pathogenic yeasts: Action mechanism evaluated by flow cytometry and biofilm growth inhibition in Candida spp. Antimicrob Agents Chemother. 2016; 60(6): 3551–7.
Li D-D, Xu Y, Zhang D-Z, Quan H, Mylonakis E, Hu D-D, Li M-B, Zhao L-X, Zhu L-H, Wang Y, Jiang Y-Y. Fluconazole assists berberine to kill fluconazole-resistant Candida albicans. Antimicrob Agents Chemother. 2013; 57(12): 6016–27.
Al Aboody MS, Mickymaray S. Anti-fungal efficacy and mechanisms of flavonoids. Antibiot (Basel, Switzerland). 2020; 9(2): 45.
- Every manuscript submitted to must observe the policy and terms set by the Dental Journal (Majalah Kedokteran Gigi).
- Publication rights to manuscript content published by the Dental Journal (Majalah Kedokteran Gigi) is owned by the journal with the consent and approval of the author(s) concerned.
- Full texts of electronically published manuscripts can be accessed free of charge and used according to the license shown below.
- The Dental Journal (Majalah Kedokteran Gigi) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License